Pluri (PLUR) Shareholder's Equity Growth (3y) (2014 - 2025)
Pluri (PLUR) Shareholder's Equity Growth (3y) (2014 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
Pluri |
21.39 Mn |
21.87 Mn |
86,000.00 |
| Date | Value |
|---|
| Dec 31, 2025 |
-33.31% |
| Sep 30, 2025 |
-30.25% |
| Jun 30, 2025 |
-30.31% |
| Mar 31, 2025 |
-28.29% |
| Dec 31, 2024 |
-27.51% |
| Sep 30, 2024 |
-26.02% |
| Jun 30, 2024 |
-54.41% |
| Mar 31, 2024 |
-69.97% |
| Dec 31, 2023 |
-45.62% |
| Sep 30, 2023 |
-39.13% |
| Jun 30, 2023 |
-35.15% |
| Mar 31, 2023 |
13.80% |
| Dec 31, 2022 |
16.21% |
| Sep 30, 2022 |
15.35% |
| Jun 30, 2022 |
13.83% |
| Mar 31, 2022 |
66.95% |
| Dec 31, 2021 |
37.90% |
| Sep 30, 2021 |
31.46% |
| Jun 30, 2021 |
26.09% |
| Mar 31, 2021 |
27.04% |
